Johnson & Johnson delves into robotics, buys Auris Health for $3.4 billion

Johnson& Johnson, one of the largest maker of health products, is now in the robotics space. The New Brunswick, New Jersey-based company announced Wednesday that it would buy surgery firm Auris Health for $3.4 billion in cash. Auris Health is a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. This latest deal is expected to bolster Johnson& Johnson ’s entry…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Source Type: news